Production (Stage)
Adicet Bio, Inc.
ACET
$0.6936
-$0.0251-3.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.08% | 17.90% | 17.59% | -19.22% | -32.77% |
| Total Depreciation and Amortization | 0.03% | 6.07% | 19.50% | 43.76% | 86.80% |
| Total Amortization of Deferred Charges | -71.15% | 30.00% | -61.17% | -59.80% | -42.86% |
| Total Other Non-Cash Items | -53.94% | -44.17% | -37.37% | 115.59% | 119.26% |
| Change in Net Operating Assets | -45.39% | -2,292.46% | -202.05% | -176.31% | -133.04% |
| Cash from Operations | -2.65% | 1.43% | -3.03% | -9.42% | -26.74% |
| Capital Expenditure | 14.96% | 74.96% | 90.04% | 89.25% | 82.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4,271.02% | -2,571.19% | 90.04% | 89.25% | 82.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -13.43% | 53,689.64% | 8,441.61% | 148.50% | 147.67% |
| Repurchase of Common Stock | -34,164.77% | -64,114.00% | -11,349.17% | 86.86% | 86.86% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.79% | 47,063.98% | 3,146.98% | 160.40% | 160.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,457.78% | -2.42% | 21.77% | 133.72% | 134.38% |